Compare JACK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JACK | PRME |
|---|---|---|
| Founded | 1951 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.7M | 601.1M |
| IPO Year | 1987 | 2022 |
| Metric | JACK | PRME |
|---|---|---|
| Price | $21.09 | $4.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $24.06 | $9.31 |
| AVG Volume (30 Days) | 1.1M | ★ 3.7M |
| Earning Date | 11-19-2025 | 11-07-2025 |
| Dividend Yield | ★ 2.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,465,314,000.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $13.99 | $1.11 |
| 52 Week High | $48.12 | $6.94 |
| Indicator | JACK | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 69.27 | 52.01 |
| Support Level | $17.98 | $3.95 |
| Resistance Level | $20.06 | $4.42 |
| Average True Range (ATR) | 1.13 | 0.30 |
| MACD | 0.28 | 0.12 |
| Stochastic Oscillator | 91.76 | 76.72 |
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.